• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Usefulness of thrombelastography platelet mapping assay to measure the antiplatelet effect of P2Y(12) receptor inhibitors and high on-treatment platelet reactivity.

作者信息

Jeong Young-Hoon, Bliden Kevin P, Antonino Mark J, Tantry Udaya S, Gurbel Paul A

出版信息

Platelets. 2013;24(2):166-9. doi: 10.3109/09537104.2012.675108. Epub 2012 May 30.

DOI:10.3109/09537104.2012.675108
PMID:22646305
Abstract
摘要

相似文献

1
Usefulness of thrombelastography platelet mapping assay to measure the antiplatelet effect of P2Y(12) receptor inhibitors and high on-treatment platelet reactivity.血栓弹力图血小板功能分析在测量P2Y(12)受体抑制剂的抗血小板作用及高治疗中血小板反应性方面的应用价值。
Platelets. 2013;24(2):166-9. doi: 10.3109/09537104.2012.675108. Epub 2012 May 30.
2
Prasugrel resistance: fact or fiction.普拉格雷抵抗：事实还是虚构？
Platelets. 2012;23(2):83-90. doi: 10.3109/09537104.2011.600478. Epub 2011 Jul 25.
3
Modification of the VerifyNow® P2Y12 test BASE channel to accommodate high levels of P2Y(12) antagonism.VerifyNow® P2Y12 检测 BASE 通道的改良以适应高水平的 P2Y(12)拮抗剂。
Platelets. 2011;22(8):619-25. doi: 10.3109/09537104.2011.579203. Epub 2011 Jun 6.
4
Mode of action of P2Y(12 ) antagonists as inhibitors of platelet function.P2Y(12) 拮抗剂作为血小板功能抑制剂的作用模式。
Thromb Haemost. 2011 Jan;105(1):96-106. doi: 10.1160/TH10-07-0482. Epub 2010 Oct 12.
5
P2Y₁₂ and EP3 antagonists promote the inhibitory effects of natural modulators of platelet aggregation that act via cAMP.P2Y₁₂ 和 EP3 拮抗剂促进了通过 cAMP 起作用的血小板聚集天然调节剂的抑制作用。
Platelets. 2011;22(7):504-15. doi: 10.3109/09537104.2011.576284. Epub 2011 May 19.
6
Human platelet protease-activated receptor-1 responsiveness to thrombin related to P2Y12 inhibition.人血小板蛋白酶激活受体-1 对凝血酶的反应性与 P2Y12 抑制有关。
Transl Res. 2013 May;161(5):414-20. doi: 10.1016/j.trsl.2012.12.009. Epub 2013 Jan 9.
7
Beyond platelet functional testing: value in the aggregate.超越血小板功能检测：总体价值
Biomark Med. 2011 Feb;5(1):5-8. doi: 10.2217/bmm.11.5.
8
A randomized trial of prasugrel versus clopidogrel in patients with high platelet reactivity on clopidogrel after elective percutaneous coronary intervention with implantation of drug-eluting stents: results of the TRIGGER-PCI (Testing Platelet Reactivity In Patients Undergoing Elective Stent Placement on Clopidogrel to Guide Alternative Therapy With Prasugrel) study.普拉格雷与氯吡格雷治疗经皮冠状动脉介入治疗（经皮冠状动脉介入治疗）后氯吡格雷高血小板反应患者的随机试验：TRIGGER-PCI（在氯吡格雷治疗的择期支架置入患者中检测血小板反应以指导普拉格雷替代治疗的试验）研究结果。
J Am Coll Cardiol. 2012 Jun 12;59(24):2159-64. doi: 10.1016/j.jacc.2012.02.026. Epub 2012 Apr 18.
9
The effect of milrinone on platelet activation as determined by TEG platelet mapping.米力农对血小板活化的影响（通过血栓弹力图血小板功能分析测定）
Anesth Analg. 2009 May;108(5):1425-9. doi: 10.1213/ane.0b013e3181981fbe.
10
Variability and treatment of high on-prasugrel platelet reactivity in patients with initial high on-clopidogrel platelet reactivity.
Int J Cardiol. 2012 Feb 9;154(3):333-4. doi: 10.1016/j.ijcard.2011.10.031. Epub 2011 Nov 8.

引用本文的文献

1
Impact of renal function on residual platelet reactivity and clinical outcomes in patients with acute coronary syndrome treated with clopidogrel.肾功能对氯吡格雷治疗急性冠脉综合征患者的血小板反应性和临床结局的影响。
Clin Cardiol. 2021 Jun;44(6):789-796. doi: 10.1002/clc.23588. Epub 2021 May 12.
2
Viscoelastic Hemostatic Assays and Platelet Function Testing in Patients with Atherosclerotic Vascular Diseases.动脉粥样硬化性血管疾病患者的粘弹性止血测定和血小板功能检测
Diagnostics (Basel). 2021 Jan 19;11(1):143. doi: 10.3390/diagnostics11010143.
3
Net platelet clot strength of thromboelastography platelet mapping assay for the identification of high on-treatment platelet reactivity in post-PCI patients.
血栓弹力描记术血小板图检测血小板网络凝块强度对 PCI 术后高血小板反应患者的识别。
Biosci Rep. 2020 Jul 31;40(7). doi: 10.1042/BSR20201346.
4
Adjunctive Cilostazol to Dual Antiplatelet Therapy to Enhance Mobilization of Endothelial Progenitor Cell in Patients with Acute Myocardial Infarction: A Randomized, Placebo-Controlled EPISODE Trial.西洛他唑辅助双联抗血小板治疗对急性心肌梗死患者内皮祖细胞动员的影响：一项随机、安慰剂对照的EPISODE试验
J Clin Med. 2020 Jun 1;9(6):1678. doi: 10.3390/jcm9061678.
5
Half-dose ticagrelor versus high-dose clopidogrel in reducing platelet reactivity in acute coronary syndrome patients with high on-clopidogrel platelet reactivity (divide study).替格瑞洛半量与高剂量氯吡格雷降低氯吡格雷高反应性急性冠脉综合征患者血小板反应性（DIVIDE 研究）。
Eur J Clin Pharmacol. 2019 Aug;75(8):1059-1068. doi: 10.1007/s00228-019-02687-0. Epub 2019 May 12.
6
Relationship between ADP-induced platelet-fibrin clot strength and anti-platelet responsiveness in ticagrelor treated ACS patients.替格瑞洛治疗的急性冠状动脉综合征患者中，ADP诱导的血小板-纤维蛋白凝块强度与抗血小板反应性之间的关系。
J Geriatr Cardiol. 2016 May;13(4):282-9. doi: 10.11909/j.issn.1671-5411.2016.04.012.
7
C-reactive protein and fibrin clot strength measured by thrombelastography after coronary stenting.冠状动脉支架置入术后通过血栓弹力图测量的C反应蛋白和纤维蛋白凝块强度
Blood Coagul Fibrinolysis. 2013 Apr;24(3):321-6. doi: 10.1097/MBC.0b013e32835cc193.